Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases
BioDrugs · 2024-03 · 38 (2) · 177-203
DOI: 10.1007/s40259-024-00644-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioDrugs, online erschienen am 22.01.2024. Verfasst von Suxiang Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, WA, 6150, Australia. Hauptthemen laut MEDLINE: Metabolic Diseases, Oligonucleotides, Antisense. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 261 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Murdoch University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, WA, 6150, Australia.
- Precision Nucleic Acid Therapeutics, Perron Institute for Neurological and Translational Science, Nedlands, WA, 6009, Australia.
- ProGenis Pharmaceuticals Pty Ltd, Bentley, WA, 6102, Australia.
- Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, WA, 6150, Australia. r.veedu@murdoch.edu.au.
- Precision Nucleic Acid Therapeutics, Perron Institute for Neurological and Translational Science, Nedlands, WA, 6009, Australia. r.veedu@murdoch.edu.au.
- ProGenis Pharmaceuticals Pty Ltd, Bentley, WA, 6102, Australia. r.veedu@murdoch.edu.au.
Förderung
- Murdoch University
Zitieren
APA
Chen, S., Heendeniya, S. N., Le, B. T., Rahimizadeh, K., Rabiee, N., Zahra, Q. U. A., & Veedu, R. N. (2024). Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases. BioDrugs, 38(2), 177-203. https://doi.org/10.1007/s40259-024-00644-7
Vancouver
Chen S, Heendeniya SN, Le BT, Rahimizadeh K, Rabiee N, Zahra QUA, et al. Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases. BioDrugs. 2024;38(2):177-203. doi:10.1007/s40259-024-00644-7
BibTeX
@article{Chen2024,
author = {Chen, Suxiang and Heendeniya, Saumya Nishanga and Le, Bao T and Rahimizadeh, Kamal and Rabiee, Navid and Zahra, Qurat Ul Ain and Veedu, Rakesh N},
title = {Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases},
journal = {BioDrugs},
year = {2024},
volume = {38},
number = {2},
pages = {177--203},
doi = {10.1007/s40259-024-00644-7}
}
EUVIMED